Cargando…
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial
BACKGROUND: In event‐driven clinical trials, study termination is based on accrual of a target number of primary efficacy events. For noninferiority trials in which superiority is conditionally examined, the ideal cohort in which to track event accrual is unclear. We used data from the ROCKET AF (Ri...
Autores principales: | Carnicelli, Anthony P., Hellkamp, Anne S., Mahaffey, Kenneth W., Singer, Daniel E., Breithardt, Günter, Halperin, Jonathan L., Hankey, Graeme J., Piccini, Jonathan P., Becker, Richard C., Nessel, Christopher C., Berkowitz, Scott D., Fox, Keith A. A., Califf, Robert M., Patel, Manesh R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649140/ https://www.ncbi.nlm.nih.gov/pubmed/34569249 http://dx.doi.org/10.1161/JAHA.121.022485 |
Ejemplares similares
-
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
por: Ugowe, Francis E., et al.
Publicado: (2021) -
Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF
por: DeVore, Adam D., et al.
Publicado: (2016) -
Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial
por: Piccini, Jonathan P., et al.
Publicado: (2014) -
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
por: Steinberg, Benjamin A., et al.
Publicado: (2015) -
Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial
por: Singer, Daniel E., et al.
Publicado: (2015)